Ultrasound Utility for Predicting Biological Behavior of Invasive Ductal Breast Cancers |
Zhang, Lei
(Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University)
Liu, Yu-Jie (Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University) Jiang, Shuang-Quan (Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University) Cui, Hao (Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University) Li, Zi-Yao (Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University) Tian, Jia-Wei (Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University) |
1 | College of Radiology, 2003. Available at: http://www.acr. org/s_acr/sec.asp?CID=882&DID=14550, 2004 |
2 | American College of Radiology. Breast imaging reporting and data system (BI-RADS), ultrasound. 4th ed. Reston, VA: American. |
3 | Au-Yong IT, Evans AJ, Taneja S, et al (2009). Sonographic correlations with the new molecular classification of invasive breast cancer. Eur Radiol, 19, 2342-48. DOI |
4 | Bauer KR, Brown M, Cress RD (2007). Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: a population-based study from the California cancer Registry. Cancer, 109, 1721-28. DOI ScienceOn |
5 | Dogan BE, Gonzalez-Angulo AM, Gilcrease M, et al (2010). Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. Am J Roentgenol, 194, 1160-66. DOI ScienceOn |
6 | Dogan BE, Turnbull LW (2012). Imaging of triple-negative breast cancer. Ann Oncol, 23, 23-9. DOI |
7 | Doreen C, Donovan A (2011). Triple negative breast cancer: therapeutic and prognostic implications. Asian Pac J Cancer Prev, 12, 2129-33. |
8 | Gordon PB, Goldenberg SL (1995). Malignant breast masses detected only by ultrasound. A retrospective review. Cancer, 76, 626-30. DOI ScienceOn |
9 | Ildefonso C, Vazquez J, Guinea O, et al (2008). The mammographic appearance of breast carcinomas of invasive ductal type: relationship with clinicopathological parameters, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol, 136, 224-31. DOI |
10 | Irshad A, Leddy R, Pisano E, et al (2013). Assessing the role of ultrasound in predicting the biological behavior of breast cancer. Am J Roentgenol, 200, 284-90. DOI |
11 | Kim SH, Seo BK, Lee J, et al (2008). Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer. Acta Oncol, 47, 1531-38. DOI |
12 | Krizmanich-Conniff KM, Paramagul C, Patterson SK, et al (2012). Triple receptor-negative breast cancer: imaging and clinical characteristics. Am J Roentgenol, 199, 458-64 DOI |
13 | Itoh A, Ueno E, Tohno E, et al (2006). Breast disease: clinical application of US elastography for diagnosis. Radiology, 239, 341-50. DOI ScienceOn |
14 | Japan Association of breast and thyroid sonology. guideline for breast ultrasound-Management and diagnosis. 2nd edn. Tokoy: Japanese 2008. |
15 | Ko ES, Lee BH, Kim HA, et al (2010). Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol, 20, 1111-17. DOI ScienceOn |
16 | Li B, Zhao X, Dai S-C, et al (2014). Associations between mammography and ultrasound imaging features and molecular characteristics of triple-negative breast cancer. Asian Pac J Cancer Prev, 15, 3555-9. DOI |
17 | Marquet KL, Wolter M, Handt S, et al (2002). Criteria of dignity in ultrasound mammography using a 10-MHz-transducer, also with regard to tumor size. Ultraschall Med, 23, 383-87 (in German). DOI |
18 | Paik S, Shak S, Tang G, et al (2004). A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med, 351, 2817-26. DOI ScienceOn |
19 | Parajuly SS, Lan PY, Yun MB, et al (2012). Diagnostic potential of strain ratio measurement and a 5 point scoring method for detection of breast cancer: Chinese experience. Asian Pac J Cancer Prev, 13, 1447- 52. DOI ScienceOn |
20 | Parajuly SS, Lan PY, Yan L, et al (2010). Breast elastography: a hospital-based preliminary study in China. Asian Pac J Cancer Prev, 11, 809-14. |
21 | Slamon DJ, Clark GM, Wong SG, et al (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-82. DOI ScienceOn |
22 | Stavros AT, Thickman D, Rapp CL, et al (1995). Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology, 196, 123-34. DOI |
23 | Perou CM (2011). Molecular stratification of triple-negative breast cancers. Oncologist, 16, 61-70. |
24 | Rizzatto GJ (2001). Towards a more sophisticated use of breast ultrasound. Eur Radiol, 11, 2425-35. DOI ScienceOn |
25 | Taucher S, Rudas M, Mader RM, et al (2003). Do we need HER- 2/neu testing for all patients with primary breast carcinoma? Cancer, 98, 2547-53. DOI ScienceOn |
26 | Wang Y, Ikeda DM, Narasimhan B, et al (2008) Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology, 246, 367-75. DOI ScienceOn |
27 | Wojcinski S, Soliman AA, Schmidt J, Makowski L, Degenhardt F, Hillemanns P (2012). Sonographic features of triplenegative and non-triple-negative breast cancer. J Ultrasound Med, 31, 1531-41. |
28 | Zonderland HM, Hermans J, Coerkamp EG (2000). Ultrasound variables and their prognostic value in a population of 1103 patients with 272 breast cancers. Eur Radiol, 10, 1562-68. DOI |